Pharmaceutical industry in India From Wikipedia‚ the free encyclopedia The Pharmaceutical industry in India is the world’s third-largest in terms of volume.[1] According to Department of Pharmaceuticals of the Indian Ministry of Chemicals and Fertilizers‚ the total turnover of India’s pharmaceuticals industry between 2008 and September 2009 was US$21.04 billion.[2] While the domestic market was worth US$12.26 billion. The industry holds a market share of $14 billion in the United States. [3] According
Premium Pharmaceutical industry Pharmacology Generic drug
Chapter 3 Closing Case: The Pharmaceutical Industry Historically‚ the pharmaceutical industry has been a profitable one. Between 2002 and 2006 the average rate of return on invested capital (ROIC) for firms in the industry was 16.45 percent. Put differently‚ for every dollar of capital invested in the industry‚ the average pharmaceutical firm generated 16.45 cents of profit. This compares with an average return on invested capital of 12.76 percent for firms in the computer hardware industry‚
Premium Pharmacology Generic drug Pharmaceutical industry
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
There is a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change
Premium Generic drug Developing country Developed country
cardiovascular disorders‚ antibiotics such as Cefzil‚ antidiabetics such as Glucophage‚ and the anti-clotting medication‚ Plavix. To continue to focus on pharmaceuticals‚ in the early years of 2000-2002‚ the company divested many of their non-pharmaceutical divisions‚ such as Clairol and the Mead-Johnson Nutritional division‚ and purchased DuPont Pharmaceuticals as well as an almost 20% share of ImClone Systems‚ which was getting ready to release a new anti-cancer drug‚ Erbitux (SEC eyes Bristol-Myers‚ 2002)
Premium Revenue Marketing Inventory
GROUP SUBMISSION: Due 27 June 2011 Midnight American Chemical Corporation CASE QUESTIONS Read the American Chemical Corporation case that was handed to you. The underlying question to be answered is should Dixon acquire the Collinsville plant. In your case write-up‚ you can discuss the questions given below. Please note that the given questions are to be used only as a guide for your discussion. You do not need to answer the questions in the sequence they are presented. You can use the spreadsheet
Premium Net present value Weighted average cost of capital Cash flow
I. General Principles of Health Care Sickness - has been one of man’s greatest adversaries Medicine - Latin word “medicus” - it is a HEALING ART - Aims to help people become more active‚ live longer‚ live happier lives with less suffering and disability. - has become a part of the health care industry * AT THE TURN OF THE 20th CENTURY (1900): - men and women were frail at the age of 40. - life expectancy was 47.3 years. * BY THE AND OF THE 20th CENTURY: - Medical Advances - Life expectancy
Premium Health care Health care provider Medicine
business of Pharmaceutical companies:- Pharmaceutical companies are not especially big in terms of revenues‚ but they are very profitable. For instance‚ in 2001‚ Pfizer was ranked 127th in the world on total revenue (US$32·2 billion) but 7th in terms of profit.29 The pharmaceutical industry is the most profitable business sector‚ with an average 16·2% profit‚ ahead of financial companies (11·6%) and beverages (10%).30 However‚ net income growth has declined‚ and growth in the value of drug
Premium Pharmacology Profit Income
because of the following reasons: (1) Americans unjustly pay up to 5 times more to fill their prescriptions than consumers in other countries; (2) The United States is the largest market for pharmaceuticals in the world‚ yet American consumers pay the highest prices for brand pharmaceuticals in the world; (3) A prescription drug is neither safe nor effective to an individual who cannot afford it; (4) Allowing and structuring the importation of prescription drugs to ensure access to
Free Pharmacology
Case Studies Report: Victoria Chemicals This report will be covering the several capitals investment aspects in which are associated with the case – Victoria Chemicals PLC (A): The Merseyside Project‚ written by Robert. F. Bruner. Introduction In the case‚ Victoria Chemicals‚ a fictional company‚ were under the pressure of its investors to improve its performance as the earnings per shares (EPS) has decreased from 250 pence in 2006 to 180 pence in 2007. Victoria Chemicals is a producer
Premium Net present value Discounted cash flow